George Perry is Semmes Distinguished University Professor and Professor of Neuroscience, Developmental and Regenerative Biology and Professor of Chemistry at The University of Texas at San Antonio. Perry is recognized in the field of Alzheimer's disease research particularly for his work on oxidative stress.

Perry received his bachelor's of arts degree in zoology with high honors from University of California, Santa Barbara. After graduation, he headed to Scripps Institution of Oceanography and obtained his Ph.D. in Marine Biology under David Epel in 1979. He then received a postdoctoral fellowship in the Department of Cell Biology in the laboratories of Drs. Bill Brinkley and Joseph Bryan at Baylor College of Medicine where he laid the foundation for his observations of abnormalities in cell structures.

In 1982, Perry joined the faculty of Case Western Reserve University, where he currently holds an adjunct appointment. He is distinguished as one of the top Alzheimer’s disease researchers with over 1000 publications , one of the top 100 most-cited scientists in neuroscience and behavior and one of the top 25 scientists in free radical research.

Perry has been cited over 115,000 times and is recognized as an ISI highly cited researcher (H=170). Perry is editor for numerous journals and is Editor-in-Chief for the Journal of Alzheimer's Disease. He is a fellow of the American Association for the Advancement of Sciences, Sigma Xi (FSX), Texas Academy of Sciences, International Engineering and Technology Institute, Association of Biotechnology and Pharmacy (FABAP), Linnean Society of London (FLS)), Royal Society of Chemistry (FRSC, CChem), Royal Society of Arts, Manufactures and Commerce (FRSA), Royal Society of Biology (FSB, CBiol, CSciTeach, and CSci), Microscopy Society of America, Royal College of Pathologists (FRCPath), Royal Microscopical Society (FRMS), World Academy of Medical Sciences (FWAS), EU Academy of Sciences and Royal Society of Medicine. He is past-president and interim-executive director of the Southwestern and Rocky Mountain Division of American Association for the Advancement of Science and past-president of the American Association of Neuropathologists. He was awarded the Society for the Advancement of Chicanos and Native American in the Sciences' (SACNAS) Distinguished Professional Mentor Award, the Senior Investigator Award of the International College of Geriatric Psychoneuropharmacology (ICGP), Top Expert in Alzheimer disease from Expertscape, Best Scientist 2022-Research.com, Martin Goland Award of the Alamo Chapter of Sigma Xi, Rous-Whipple Award of ASIP, Scientist of the Year 2021-BioPub, Research and Education Lifetime Achievement Award, Global Association for the Study of Neurodegenerative Diseases, Udaan Award, Albert Nelson Marquis Lifetime Achievement Award, Senior Fulbright Scholar and the National Plaque of Honor of Panama for Excellence in Neuroscience. He was elected a Foreign Corresponding Member of the Academy of Sciences of Lisbon, Foreign Correspondent Member of the Spanish Royal Academy of Sciences, Corresponding Member of the Mexican Academy of Sciences, Member of the Dana Alliance for Brain Initiatives, Member of the Iberoamerican Molecular Biology Organization and the Portuguese Diaspora Council.

Perry's research is primarily focused on how Alzheimer disease develops and the physiological consequences of the disease at a cellular level. He is currently working to determine the sequence of events leading to damage caused by and the source of increased oxygen radicals.